These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 818622)

  • 1. [Letter: Fetomaternal blood incompatibilities in Rh positive women].
    Senecal J; Le Marec B; Genetet B; Bonnefoy O; Le Freche J
    Nouv Presse Med; 1976 May; 5(18):1211. PubMed ID: 818622
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of Rh immune globulin.
    Gorman JG
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transfusion complications caused by rarely occurring non-D antibodies].
    Orv Hetil; 1983 Feb; 124(9):545. PubMed ID: 6405339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Editorial: Fetomaternal blood incompatibilities in Rh-positive women].
    Lepage F; Le Lorier G; Boreau T; Grégut R; Fondraz T
    Nouv Presse Med; 1975 Dec; 4(42):2981-2. PubMed ID: 815882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of irregular antibodies found in patients and in pregnancy tests].
    Busch H; Rothe B von E; Hochweller E
    Munch Med Wochenschr; 1970 Feb; 112(8):341-51. PubMed ID: 4997704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood group incompatibility in the ABO and Rh(D) systems in women with a blood transfusion anamnesis].
    Dzierzkowa-Borodej W; Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):341-3. PubMed ID: 4193011
    [No Abstract]   [Full Text] [Related]  

  • 8. [Materno-fetal isoimunization by Rh].
    Gibertini A; Dodesini G; Erba GF
    Quad Clin Ostet Ginecol; 1967 Aug; 22(8):536-50. PubMed ID: 4976396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the demonstration of fetal erythrocytes in the maternal blood during the postpartum period].
    Cordier P; Madeline P; Guillaumin JP; Jeanney JC; Couzineau P
    Ann Biol Clin (Paris); 1967; 25(7):903-11. PubMed ID: 4965531
    [No Abstract]   [Full Text] [Related]  

  • 11. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-D treatment after mismatched transfusion: prevention of Rh sensitization].
    Schellong G; Grimm W
    Dtsch Med Wochenschr; 1970 Dec; 95(51):2555-9. PubMed ID: 4998366
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):476-94. PubMed ID: 5000274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood group incompatibility in childhood].
    Felsenreich G; Rosenkranz A
    Wien Med Wochenschr; 1970 May; 120(22):397-400. PubMed ID: 4996901
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-invasive antenatal RHD typing.
    Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
    Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal screening in the serodiagnosis of blood group sensitization.
    Wieczorek P; Wegrzecki R
    Acta Eur Fertil; 1973 Jun; 4(2):85-7. PubMed ID: 4206119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.